Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 6, 2022
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
[ Mon, Jun 06th 2022
] - WOPRAI
Sun, June 5, 2022
[ Sun, Jun 05th 2022
] - WOPRAI
Fri, June 3, 2022
[ Fri, Jun 03rd 2022
] - WOPRAI
[ Fri, Jun 03rd 2022
] - WOPRAI
[ Fri, Jun 03rd 2022
] - WOPRAI
[ Fri, Jun 03rd 2022
] - WOPRAI
[ Fri, Jun 03rd 2022
] - WOPRAI
[ Fri, Jun 03rd 2022
] - WOPRAI
Jack Allen Initiated (ALLO) at Hold and Held Target at $11 on, Jun 3rd, 2022
Jack Allen of Baird, Initiated "Allogene Therapeutics, Inc." (ALLO) at Hold and Held Target at $11 on, Jun 3rd, 2022.
Jack has made no other calls on ALLO in the last 4 months.
There are 2 other peers that have a rating on ALLO. Out of the 2 peers that are also analyzing ALLO, 1 agrees with Jack's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $9 on, Tuesday, May 24th, 2022
This is the rating of the analyst that currently disagrees with Jack
- Dane Leone of "Raymond James" Maintained at Buy with Decreased Target to $13 on, Thursday, May 5th, 2022
